MYELOMA
Clinical trials for MYELOMA explained in plain language.
Never miss a new study
Get alerted when new MYELOMA trials appear
Sign up with your email to follow new studies for MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New treatment hope for elderly blood cancer patients
Disease control OngoingThis study is testing different combinations of medications for older adults (65-80 years) who have newly diagnosed multiple myeloma and cannot undergo a stem cell transplant. Researchers want to see if adding certain drugs to standard treatment helps control the cancer better an…
Matched conditions: MYELOMA
Phase: PHASE3 • Sponsor: Poitiers University Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Four-Drug attack on blood cancer shows promise in new trial
Disease control OngoingThis study is testing a combination of four medications (daratumumab, carfilzomib, lenalidomide, and dexamethasone) as the first treatment for people newly diagnosed with multiple myeloma, a cancer of plasma cells in the bone marrow. It aims to see how well this combination works…
Matched conditions: MYELOMA
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Scientists re-engineer Patients' own cells to hunt down blood cancers
Disease control OngoingThis is an early-stage safety study testing a new type of cell therapy for adults with certain recurring B-cell blood cancers (like lymphoma, myeloma, or CLL) that have not responded to standard treatments. Doctors take a patient's own immune cells (T cells), genetically modify t…
Matched conditions: MYELOMA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New drug added to stem cell transplant shows promise for tough blood cancer
Disease control OngoingThis study is testing if adding a targeted drug called belantamab mafodotin before and after a stem cell transplant helps people with multiple myeloma. The goal is to see if this combination is safe and more effective at keeping the cancer in check compared to past treatments. It…
Matched conditions: MYELOMA
Phase: PHASE2 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC
-
Scientists track tiny doses of experimental drug to map tumors
Knowledge-focused OngoingThis early study aims to understand how a new drug called PUH71 moves through the body and gathers in tumors when given in very small amounts. Researchers will use PET scans to track the drug in patients with various cancers, including lymphoma, myeloma, and solid tumors. The res…
Matched conditions: MYELOMA
Phase: EARLY_PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC
-
Can exercise prep older patients for powerful cancer treatment?
Knowledge-focused OngoingThis study is testing whether a special exercise program is safe and practical for older adults with blood cancers before they receive CAR-T cell therapy. Researchers want to see if patients can stick with the program and if it helps improve their strength and fitness. The goal i…
Matched conditions: MYELOMA
Phase: NA • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:31 UTC